From £6.99 per month
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares


Join for as low as £6.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Results: HAYD

Search articles by EPIC code

Haydale – Interim Results Show Placing On The Way: SELL

AIM-listed graphene play Haydale (HAYD) announced its interim results to December 2021 this morning and despite the advertised £3.84 million of cash, yet another placing is surely inevitable. Revenues fell from £1.28 million to £1.19 million, pre-tax losses increased from £1.93 million to £2.46 million year on year – what’s not to like? But the real problem is the balance sheet.


Haydale – FY Results: A “Robust Trading Performance”? Er…

AIM-listed graphene products company Haydale (HAYD) has released its full year results to June 30 2021. Amongst the highlights we are told of a “robust trading performance” and the “Summary of Results” shows that cash outflow from operations was down by 52% whilst cash at year end was up by 100% at £1.64 million. So all is well, right? Think again…..


Haydale – Ouzo on Cornflakes as Placing at just 6p announced

In my last piece on AIM-listed Haydale (HAYD) at the beginning of this month I discussed a ramparoonie RNS revealing an undeclared related party and a tin-pot organisation casting a very different light on matters as presented by the company. What was the point? Of course – it was a pre-placing ramp and this morning it was time for Ouzo on cornflakes as Haydale revealed a fundraise at just 6p per share. That, against a peak last week of 7.55p.


BREAKING EXPOSE: Haydale – Another RNS Reach Ramparoonie, This Time With a Piffling Undeclared Related Party

AIM-listed Haydale (HAYD) has announced a Memorandum of Understanding with a company called Viritech Limited via and RNS Reach this morning. Of course, and RNS Reach is not a full RNS and should be treated more as marketing material, certainly with no implied financial impact. A trip to Companies House shows us why……

Page 2 of 9 (86 articles)
Subscribe to our newsletter

Daily digest of our latest stories.

Search ShareProphets

Complete Coverage

Recent Comments